Episode 24

How AI is Transforming Drug Development: Reflections from AAPS - PharmSci 360 with Dr. Mark Arnold

Dr. Mark Arnold, a distinguished bioanalytical thought leader with an impressive track record in supporting drug development programs. Mark is the Owner and Principal at Bioanalytical Solution Integration, where he provides strategic counsel on complex bioanalytical assays and regulatory compliance. With over 35 years of experience, including leadership roles at BMS and Labcorp, Mark has become a key figure in the biotech and pharma industries. He is also an AAPS Fellow and a founder of the Global Bioanalysis Consortium.

01:05 - Career Reflections and Contributions to Drug Development

05:28 - Understanding the Integration of Drug Development

09:30 - What Would You Change? Embracing Career Risks in Pharma

11:32 - Navigating Career Paths: Small vs. Large Companies

16:09 - NEW NEWS! - Can Electrical Fields Disrupt Cancer?

23:28 - The Role of AI in Drug Development

31:13 - Encouraging Innovation in a Regulated Industry

Follow Mark, Chad and Gregory:

Please donate to: Samaritan’s Purse

https://www.samaritanspurse.org/

Mark Arnold - https://www.linkedin.com/in/markearnoldphd/

Blog - https://bioanalysisandbiomarkers.blogspot.com/